Clinical Trials Logo
NCT number NCT03351738
Study type Interventional
Source MedImmune LLC
Contact AstraZeneca Clinical Study Information Center
Phone 1-877-240-9479
Email information.center@astrazeneca.com
Status Not yet recruiting
Phase Phase 2
Start date December 7, 2017
Completion date December 27, 2018

Clinical Trial Summary

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease


Clinical Trial Description

A Randomized, Double-blind, Placebo-controlled, Parallel-designed Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Subjects with Stable Coronary Heart Disease


Study Design


Related Conditions & MeSH terms